Combined with previous research, we speculated that 5-DR acts as a small-molecule inhibitor of the NLRP3 inflammasome and holds promise as a therapeutic agent for the treatment of ALI. The gene discussed is NLRP3; the disease is acute respiratory distress syndrome.